Arden Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,168
| Closed | -$245K | – | 243 |
|
|
2023
Q2 | $245K | Sell |
1,168
-1,217
| -51% | -$255K | 0.04% | 217 |
|
|
2023
Q1 | $481K | Buy |
2,385
+361
| +18% | +$72.8K | 0.09% | 181 |
|
|
2022
Q4 | $441K | Sell |
2,024
-679
| -25% | -$148K | 0.09% | 185 |
|
|
2022
Q3 | $531K | Buy |
2,703
+299
| +12% | +$58.7K | 0.13% | 149 |
|
|
2022
Q2 | $515K | Buy |
2,404
+372
| +18% | +$79.7K | 0.12% | 164 |
|
|
2022
Q1 | $577K | Buy |
2,032
+216
| +12% | +$61.3K | 0.11% | 165 |
|
|
2021
Q4 | $684K | Buy |
+1,816
| New | +$684K | 0.12% | 166 |
|